期刊文献+

强化降脂治疗的临床策略及应用 被引量:9

Clinical strategy and application on intensive lipid-lowering treatment
原文传递
导出
摘要 大量研究证实强化降脂治疗能阻断或逆转动脉粥样硬化病变进展。目前认为,对于急性冠脉综合征患者的强化治疗时间至少应坚持2年。而稳定型冠心病也需大幅度降低胆固醇。但需要认识到大幅度降低胆固醇的潜在危害和局限性,降脂不是越低越好,同时也要监测可能发生的不良反应。 Summary: The massive researches confirmed intensive lipid-lowering therapy can block or reverse the progress of atherosclerosis. At present it has been believed that the term of intensive therapy should remain at least for 2 years in the patients with acute coronary syndrome. Significant reduction in the cholesterol is also essential for the patients with stable coronary heart disease. It should be realized that markedly lowering the cholesterol has latent damage and limitation. Lower lipid level does not mean better status. The adverse effects are also need to be monitored simultaneously.
作者 赵水平
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第1期5-7,共3页 Chinese Journal of Practical Internal Medicine
关键词 降血脂药 高胆固醇血症 antilipemic agents hypercholesterolemia
  • 相关文献

参考文献7

  • 1Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia [ J ]. Circulation ,2008,118:672 - 677.
  • 2Spencer FA,Allegrone J, Goldberg R J, et al. Association of statin therapy with outcomes of acute coronary syndrome: The GRACE study[ J]. Ann Intern Med ,2004,140:857 - 866.
  • 3Cannon CP, I Braunwald E, McCabe C,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [ J]. N Engl J Med ,2004,350 : 1495 - 1504.
  • 4LaRosa JC, Grundy SM, Waters DD, et al. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease [ J ]. N Engl J Med ,2005,352 : 1425 - 1435.
  • 5Pedersen TR, Faergeman O, John JP, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL Study: A randomized controlled trial [ J ]. JAMA, 2005,294:2437 - 2445.
  • 6Williams K J, Feig JE, Fisher EA. Rapid regression of atherosclerosis: insights from the clinical and experimental literature [ J ]. Nat Clin Pract Cardiovasc Med,2008,5 (2) :91 -102.
  • 7O'Keefe JH, Cordain L, Harris WH, et al. Optimal low-density lipoprotein is 50 to 70 mg/dL, Lower is better and physiologically normal [ J ]. J Am Coll Cardiol,2004,43:2142 - 2146.

同被引文献52

  • 1韩英,梁灿炎,王治伟.血脂康治疗2型糖尿病血脂异常患者55例[J].广东药学院学报,2004,20(5):558-558. 被引量:7
  • 2周慧,曾兆良.血脂康辛伐他汀治疗2型糖尿病并血脂异常[J].医药论坛杂志,2005,26(21):10-11. 被引量:4
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 4Tsisara S,Elisaf M,Mikhailidis DP.Early vascular benefits of statin therapy[J].Curr Med Res Opin,2007,19(6):540-969.
  • 5他汀类药物防治缺血性脑卒中/短暂性脑缺血发作的专家共识组.他汀类药物防治缺血性脑卒中/短暂性脑缺血发作的专家共识(更新版).中华内科杂志,2008,47(10):847-875.
  • 6中华心血管杂志,2000,:4209-4212.
  • 7李端,药理学.第6版.人民卫生出版社,2003:283.
  • 8李端.药理学[M].第6版.北京:人民卫生出版社,2003:283.
  • 9Rose R. Ather oscleosis: an inflammatory disease. NEngt J Med, 1999, 340(2):115-126.
  • 10卫生部卫生统计信息中心.2008年中国卫生事业发展情况统计公报,2009.

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部